Marek Health: Hormone-optimization specialist with a labs-and-coaching emphasis
New research shows promise for Novo Nordisk's IcoSema, a combination of once-weekly insulin icodec and semaglutide currently being tested in people with type 2 diabetes
Muscle pain is another reported side effect, though less common
Throughout, the conversation emphasizes practical interventionsfrom specific foods and exercises to communication strategiesthat can improve sexual wellness and overall health
History of pancreatitis , thyroid issues, or diabetic retinopathy, as these conditions require special consideration when prescribing GLP-1 receptor agonists
Some patients respond better to one medication than the other, which is why treatment selection should be guided by a physician